New Jersey A 4550: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Status: Introduced, Referred to Assembly Financial Institutions and Insurance Committee (as of 2026-03-10)

State: New Jersey · Session: 222 · Bill: A 4550

Sponsors: Murphy, Carol A.

View New Jersey A 4550 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.